VCTRYSRS US EQ INCM ENHNCD WTD ETF logo

CDC - VCTRYSRS US EQ INCM ENHNCD WTD ETF Share Price

$46.24 0.9  1.9%

Sector
Size
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6339
Bullish
Bearish
Unlock CDC Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 01st Jan 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CDC Revenue Unlock CDC Revenue

Net Income

CDC Net Income Unlock CDC Revenue

Normalised EPS

CDC Normalised EPS Unlock CDC Revenue

PE Ratio Range

CDC PE Ratio Range Unlock CDC Revenue

Dividend Yield Range

CDC Dividend Yield Range Unlock CDC Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CDC EPS Forecasts Unlock CDC Revenue
Profile Summary

Directors

No Management Information.

Last Annual January 1st, 1970
Last Interim January 1st, 1970
No. of Shareholders: n/a
No. of Employees: n/a
Sector
Industry
Index
Exchange NASDAQ Global Market
Shares in Issue
Free Float (0.0%)
Eligible for
ISAs
SIPPs
+
Address
Web
Phone +
CDC Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CDC
Upcoming Events for CDC
Similar to CDC
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.